Device Trial Radar · NCT06889298
EXOMIND (BTL-699) for the Reduction of Food Cravings
Last checked: Nov 20, 2026Latest source record: Sep 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
29
Actual
Start
Feb 9, 2023
Primary completion
Jun 20, 2023
Study completion Jun 20, 2023
Sponsor
- Lead sponsor
- BTL Industries Ltd.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 21, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to evaluate if the treatment with BTL-699 device is able to temporarily reduce food cravings in adults above the age of 22 years. The main question it aims to answer is: Does the treatment with BTL-699 device provide a temporary reduction of food cravings? Participants will be asked to: * Undergo 4 to 6 treatments * Undergo weight measurements * Complete the Food Cravings Questionnaire-Trait * Complete the Therapy Comfort Questionnaire * Complete the Satisfaction Questionnaire
Conditions
- Food Cravings
Interventions
Treatment with BTL-699Device
Four to six transcranial magnetic stimulation treatments with the BTL-699 device will be delivered over the left dorsolateral prefrontal cortex, spaced 2 to 3 days apart. The intensity will be adjusted according to the subject's feedback, up to 100% of the individual's motor threshold.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Assessment of Change in Food CravingsTime frame: 15 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
National Institute for Mental Health
Klecany, Czechia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.